Clinical trial
Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin
NCT00210041 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2004
- Completion date
- December 31, 2012
- Enrollment
- 50 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.